Dow Down0.78% Nasdaq Down1.13%

Ampio Pharmaceuticals, Inc. (AMPE)

-NYSE MKT
4.18 Up 0.01(0.24%) May 3, 4:01PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Total Revenue 469   487   184   21  
Cost of Revenue244  37  88   -  
Gross Profit 225   450   97   21  
Operating Expenses
Research Development5,778  4,711  3,811  4,660  
Selling General and Administrative4,756  3,411  4,007  2,961  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (10,308) (7,672) (7,722) (7,600)
Income from Continuing Operations
Total Other Income/Expenses Net -   -  8  8  
Earnings Before Interest And Taxes(10,622)(7,787)(7,714)(7,591)
Interest Expense -   -   -   -  
Income Before Tax(10,622)(7,787)(7,714)(7,591)
Income Tax Expense -   -   -   -  
Minority Interest616  421  358  308  
Net Income From Continuing Ops(10,006)(7,366)(7,355)(7,284)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (10,006) (7,366) (7,355) (7,284)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (10,006) (7,366) (7,355) (7,284)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.